autologous CAR T cells RD14-01
Term · Oncology and biomedicine · MLC-T-ONC-011522
A preparation of autologous T lymphocytes that are genetically engineered to express a chimeric antigen receptor (CAR) that targets an as of yet unidentified tumor-associated antigen (TAA), with potential immunomodulatory and antineoplastic activities. Upon administration of autologous CAR T cells RD14-01, the T cells target, bind to and induce selective cytotoxicity in tumor cells expressing the TAA.
| Identifier | MLC-T-ONC-011522 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | autologous CAR-T cells RD14-01 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-011522",
"term": "autologous CAR T cells RD14-01",
"field": "Oncology and biomedicine",
"definition": "A preparation of autologous T lymphocytes that are genetically engineered to express a chimeric antigen receptor (CAR) that targets an as of yet unidentified tumor-associated antigen (TAA), with potential immunomodulatory and antineoplastic activities. Upon administration of autologous CAR T cells RD14-01, the T cells target, bind to and induce selective cytotoxicity in tumor cells expressing the TAA.",
"synonyms": [
"autologous CAR-T cells RD14-01"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/autologous-car-t-cells-rd14-01/"
}
Record 2,856 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.